Assertio Holdings (ASRT) Income from Continuing Operations (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Income from Continuing Operations came in at 18856000.0 in Q1 2026, down 39.72% year-on-year from 31278340.22 in Q1 2025, and down 58.56% quarter-over-quarter from 11892000.0 in Q4 2025.

Assertio Holdings (ASRT) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Income from Continuing Operations across 8 years of filings, most recently posting 18856000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 18856000.0, down 39.72% year-over-year; the trailing twelve-month figure through Mar 2026 was 35655000.0 (down 16.55% YoY), and the FY2025 annual result was 30340000.0, down 40.27% from the prior year.
  • Income from Continuing Operations came in at 18856000.0 for Q1 2026 at Assertio Holdings, down from 11892000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 88594000.0 in Q4 2022 to a low of 279544000.0 in Q3 2023.
  • The 5-year median for Income from Continuing Operations is 3625000.0 (2024), against an average of 17235823.53.
  • Across the five-year window, Income from Continuing Operations jumped 1811.83% in 2022 and slumped 6797.27% in 2023, its largest moves.
  • Assertio Holdings' Income from Continuing Operations stood at 88594000.0 in 2022, then sank by 164.78% to 57393000.0 in 2023, then jumped by 81.62% to 10549000.0 in 2024, then declined by 12.73% to 11892000.0 in 2025, then plunged by 58.56% to 18856000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 18856000.0 (Q1 2026), 11892000.0 (Q4 2025), and 11445000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn -18.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.86 Mn
Dec 31, 2025 -11.89 Mn
Sep 30, 2025 11.45 Mn
Jun 30, 2025 -16.35 Mn
Mar 31, 2025 -13.50 Mn
Dec 31, 2024 -10.55 Mn
Sep 30, 2024 -2.92 Mn
Jun 30, 2024 -3.63 Mn
Mar 31, 2024 -4.48 Mn
Dec 31, 2023 -57.39 Mn
Sep 30, 2023 -279.54 Mn
Jun 30, 2023 8.47 Mn
Mar 31, 2023 -3.48 Mn
Dec 31, 2022 88.59 Mn
Sep 30, 2022 4.17 Mn
Jun 30, 2022 7.83 Mn
Mar 31, 2022 9.06 Mn
Dec 31, 2021 4.63 Mn
Sep 30, 2021 3.74 Mn
Jun 30, 2021 -14.17 Mn